-
TRANSPORTING REAL-WORLD OUTCOMES OF PATIENTS FROM THE UNITED STATES TO THE UNITED KINGDOM: THE CHALLENGING USE CASE OF PATIENTS WITH SCHIZOPHRENIA
Aug 11, 2026, 17:16 PM -
"IS THE GRASS GREENER ON THE OTHER SIDE?" GLOBALISATION OF INTERNATIONAL PRICE REFERENCING FOR MEDICINES
Aug 11, 2026, 17:16 PM -
HEALTHCARE COSTS IN ESSENTIAL THROMBOCYTHEMIA: A NATIONWIDE CLAIMS-BASED ANALYSIS IN SOUTH KOREA
Aug 11, 2026, 17:16 PM -
ASSOCIATION BETWEEN FIRST-LINE CD38-CONTAINING REGIMENS AND OVERALL SURVIVAL VS. REGIMENS WITHOUT ANTI-CD38 EXPOSURE IN JAPANESE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A REAL-WORLD STUDY USING JAPAN MDV CLAIMS DATABASE
Aug 11, 2026, 17:16 PM -
FIRST-YEAR COST COMPARISON OF FLAURA2 VERSUS IV MARIPOSA IN EGFR-MUTATED ADVANCED NSCLC IN ARGENTINA
Aug 11, 2026, 17:16 PM -
AI-ASSISTED DOSSIER AUTHORING FOR SWISS BAG REIMBURSEMENT SUBMISSIONS: VALIDATION ACROSS THREE SUBMISSION DOCUMENT TYPES
Aug 11, 2026, 17:16 PM -
HEALTH STATE UTILITIES BEFORE AND AFTER REVASCULARIZATION FOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A SYSTEMATIC LITERATURE REVIEW AND META-REGRESSION ANALYSIS
Aug 11, 2026, 17:16 PM -
WHICH EVIDENCE COUNTS? REAL-WORLD DATA, SURROGATE ENDPOINTS, AND SINGLE-ARM TRIALS IN EU JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
EXTERNAL VALIDATION OF THE ADA DIABETES RISK SCORE FOR POPULATION-LEVEL DIABETES SCREENING IN THE UNITED ARAB EMIRATES
Aug 11, 2026, 17:16 PM -
USE OF PRIMARY CARE RESOURCES AMONG PATIENTS WHO ARE FREQUENT VISITORS (ONE YEAR, TWO YEARS, AND PERSISTENT) AND NON-FREQUENT VISITORS IN THIN® PRIMARY CARE DB IN BELGIUM AND SPAIN DURING 2023 TO 2025 PERIOD
Aug 11, 2026, 17:16 PM -
REPLACING PHENOTYPIC TESTING WITH RAPID MOLECULAR DIAGNOSTICS FOR DRUG-RESISTANT TB IN HIGH-BURDEN SETTINGS: A COST-EFFECTIVENESS ANALYSIS
Aug 11, 2026, 17:16 PM -
SAFETY AND EFFECTIVENESS OF HEMODIALYSIS ACCESS CREATION USING HEMODIALYSIS RELIABLE OUTFLOW IN END-STAGE RENAL DISEASE: SYSTEMATIC REVIEW
Aug 11, 2026, 17:16 PM -
EVIDENCE EXPECTATIONS VS. EVIDENTIARY REALITY: LESSONS FROM MISSING INFORMATION NOTICES IN RARE ONCOLOGY JOINT CLINICAL ASSESSMENTS
Aug 11, 2026, 17:16 PM -
IMPROVING CLINICAL AND ECONOMIC OUTCOMES IN TRANSARTERIAL CHEMOEMBOLISATION: A BUDGET IMPACT ANALYSIS OF BALLOON TACE IN HEPATOCELLULAR CARCINOMA
Aug 11, 2026, 17:16 PM -
ARE SPONTANEOUSLY REPORTED SYMPTOMS THE MOST BOTHERSOME TO PATIENTS? EXPLORING AN UNDERLYING ASSUMPTION IN CLINICAL OUTCOMES ASSESSMENTS RESEARCH
Aug 11, 2026, 17:16 PM -
FROM PICO TO ECONOMIC EVALUATION: A STRUCTURED FRAMEWORK FOR ALIGNING EU JOINT CLINICAL ASSESSMENT (JCA) EVIDENCE WITH NATIONAL ECONOMIC EVALUATIONS
Aug 11, 2026, 17:16 PM -
ALIGNING EVIDENCE GENERATION WITH EVOLVING MARKET ACCESS PATHWAYS AND REGULATORY, HTA, PAYER, AND IMPLEMENTATION NEEDS: A UK EXAMPLE
Aug 11, 2026, 17:16 PM -
PREVENTION PAYS OFF: ADULT RESPIRATORY IMMUNISATION AND THE ROAD TO UNIVERSAL HEALTH COVERAGE IN SOUTH AFRICA
Aug 11, 2026, 17:16 PM -
WHO/EUROPE'S ACCESS TO NOVEL MEDICINES PLATFORM: ADVANCING EQUITABLE ACCESS THROUGH MULTI-STAKEHOLDER COLLABORATION
Aug 11, 2026, 17:16 PM -
WHO VALUES VALUE IN HEALTHCARE? A SYSTEMATIC LITERATURE REVIEW OF PATIENT ENGAGEMENT IN VALUE ASSESSMENT FRAMEWORKS
Aug 11, 2026, 17:16 PM
